Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Vaccines”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Testing effectiveness (Phase 2)Study completedNCT01187433
What this trial is testing

Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America

Who this might be right for
DengueDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 150
Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Early research (Phase 1)Study completedNCT02021968
What this trial is testing

Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)UnknownNCT02406729
What this trial is testing

Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine

Who this might be right for
Dengue
Butantan Institute 16,935
Early research (Phase 1)Study completedNCT03416036
What this trial is testing

Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 64
Not applicableActive Not RecruitingNCT06898775
What this trial is testing

Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.

Who this might be right for
Dengue Vaccines
Fundación Vacunar 112,345
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Testing effectiveness (Phase 2)Study completedNCT00993447
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Who this might be right for
DengueDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 600
Testing effectiveness (Phase 2)Study completedNCT03746015
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults

Who this might be right for
Dengue Fever
Takeda 30
Testing effectiveness (Phase 2)Study completedNCT02824198
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 118
Large-scale testing (Phase 3)Study completedNCT06060067
What this trial is testing

Dengue Vaccine in Healthy Children, Teenagers and Adults in India

Who this might be right for
Healthy Volunteers
Takeda 480
Testing effectiveness (Phase 2)Study completedNCT05710224
What this trial is testing

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)

Who this might be right for
Dengue
Butantan Institute 1,364
Early research (Phase 1)Study completedNCT02684383
What this trial is testing

Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05229354
What this trial is testing

Dengue Controlled Human Infection Model in Dhaka, Bangladesh

Who this might be right for
Dengue
Beth Kirkpatrick 192
Early research (Phase 1)Study completedNCT01110551
What this trial is testing

Tetravalent Chimeric Dengue Vaccine Trial

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableStudy completedNCT06418854
What this trial is testing

Dengue Vaccine Hesitancy Among International Travelers

Who this might be right for
Vaccine Hesitancy
Mahidol University 390
Testing effectiveness (Phase 2)Study completedNCT01843621
What this trial is testing

A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

Who this might be right for
Dengue
U.S. Army Medical Research and Development Command 7
Early research (Phase 1)Study completedNCT04786457
What this trial is testing

ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)

Who this might be right for
Dengue
University of Maryland, Baltimore 10
Testing effectiveness (Phase 2)Study completedNCT01488890
What this trial is testing

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 390
Not applicableActive Not RecruitingNCT07158190
What this trial is testing

Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

Who this might be right for
Dengue
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Load More Results